Drug
Vaniprevir clinical trials
Also written MK-7009.
- studies test it
- 12
- open now
- 0
- in phase 3
- 3
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
- MK-7009
- 10
Studies by the year they started
12 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 5
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vaniprevir is read from its arms, and is right about nine times in ten.
Testing it · 12
- Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)CompletedPhase 1Merck Sharp & Dohme LLCNCT01678131Written as Vaniprevir 600 mg
- A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)CompletedPhase 2Merck Sharp & Dohme LLCNCT00943761Written as Vaniprevir 600 mg b.i.d.
- Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)CompletedPhase 3Merck Sharp & Dohme LLCNCT01405560Written as Vaniprevir
- Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)CompletedPhase 3Merck Sharp & Dohme LLCNCT01370642Written as vaniprevir
- Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)CompletedPhase 3Merck Sharp & Dohme LLCNCT01405937Written as vaniprevir
- Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)TerminatedPhase 1Merck Sharp & Dohme LLCNCT00954993Written as Vaniprevir
- A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)CompletedPhase 2Merck Sharp & Dohme LLCNCT00880763Written as Vaniprevir
- A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)CompletedPhase 1Merck Sharp & Dohme LLCNCT01010906Written as Vaniprevir 300 mg
- Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)CompletedPhase 2Merck Sharp & Dohme LLCNCT00704184Written as Comparator: Vaniprevir
- Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)CompletedPhase 2Merck Sharp & Dohme LLCNCT00704405Written as Vaniprevir
- Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)WithdrawnPhase 2Merck Sharp & Dohme LLCNCT00895882Written as vaniprevir (MK7009)
- Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00518622Written as Comparator: MK7009
Codes
What other systems call vaniprevir · ClinicalTrials.gg INT005426
- MeSH (NLM) C540393vaniprevirOne source NLM
- UNII (FDA) CV3X74AO1HVANIPREVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q7914945vaniprevirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152828VaniprevirOne source FDA
- DrugBank DB11929One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C540393 | vaniprevir | One source NLM |
| UNII (FDA) | CV3X74AO1H | VANIPREVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7914945 | vaniprevir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152828 | Vaniprevir | One source FDA |
| DrugBank | DB11929 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.